Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01242787 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: LB80380
DRUG: Entecavir 0.5 mg

Sponsor

LG Life Sciences